Cargando…
Melanoma Brain Metastases in the Era of Target Therapies: An Overview
Malignant melanoma is the third most common type of tumor that causes brain metastases. Patients with cerebral involvement have a dismal prognosis and their treatment is an unmet medical need. Brain involvement is a multistep process involving several signaling pathways such as Janus kinase/signal T...
Autores principales: | Becco, Paolo, Gallo, Susanna, Poletto, Stefano, Frascione, Mirko Pio Manlio, Crotto, Luca, Zaccagna, Alessandro, Paruzzo, Luca, Caravelli, Daniela, Carnevale-Schianca, Fabrizio, Aglietta, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352598/ https://www.ncbi.nlm.nih.gov/pubmed/32575838 http://dx.doi.org/10.3390/cancers12061640 |
Ejemplares similares
-
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients
por: Berrino, E., et al.
Publicado: (2021) -
Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
por: Carnevale-Schianca, Fabrizio, et al.
Publicado: (2021) -
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma
por: Nepote, Alessandro, et al.
Publicado: (2022) -
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells
por: Gammaitoni, Loretta, et al.
Publicado: (2015) -
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
por: Giraudo, Lidia, et al.
Publicado: (2023)